During the past decade, Mary Potter Oncology Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Potter Oncology Centre" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mary Potter Oncology Centre" are "Melanoma" (2 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Malignant Melanoma" (1 trials), "Metastases" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Mary Potter Oncology Centre" in a lesser frequency.

Most popular intervention types in "Mary Potter Oncology Centre" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Bevacizumab [Avastin]" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials) and "MDX-010 (anti-CTLA4) monoclonal antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mary Potter Oncology Centre" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Mary Potter Oncology Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mary Potter Oncology Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mary Potter Oncology Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".